Abstract
Cancer is the second leading cause of death worldwide, and its early detection, associated with the appropriate therapeutic regimen, is the best option to substantially reduce the risk of mortality. Despite advances in the study of biomarkers for early diagnosis, strategies for their detection still require improvements in both selectivity for capturing circulating tumor cells (CTCs), and…